Let them contemplate the following phase.
"making it an excellent fit to support Mesoblast’s
commercial growth strategy over the next five years,” said Silviu Itescu, Chief Executive of Mesoblast.
Going it alone? Or
Leaving option open sending clear message to Novartis!
Any judge and any reasonable person anywhere in the world would consider that the time Novartis has had to consider results enough, imo.
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility, page-41
-
- There are more pages in this discussion • 411 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |